We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Horizon Discovery Group Plc | LSE:HZD | London | Ordinary Share | GB00BK8FL363 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 184.50 | 184.50 | 185.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
09/9/2015 08:29 | Added 6K on the news. Saw these guys at an investor event and was impressed then.Happy to see the share price perform similar to ABCAM too! | melody9999 | |
09/9/2015 07:36 | Small holding for me bought few months ago. This looks good news and let's hope it gets the price moving up. Bags of potential here if they can crack it. | ayl30 | |
09/9/2015 07:28 | Agreed, the longterm potential becoming clearer with each bit of news. | phowdo | |
09/9/2015 07:08 | More good news today. Need to try and push on to 170. Hopefully the down trend is over for this share and with all the positive news recently then I can only see a great future here. | oggyrocks | |
12/8/2015 03:12 | Ah, i see two of the key characters in the IP battle described above, Dr. Charpentier and Dr. Feng Zhang, joined the Horizon Scientific Advisory Board in 2014... | rambutan2 | |
12/8/2015 02:59 | HZD licence its CRISPR tech from the Broad Institute, and from ERP Genomics, but beyond that I'm not sure if the fund raising and IP battles described in the two links below are particularly relevant to it, although illustrate the excitement around the tech. Worth a read though... | rambutan2 | |
03/8/2015 15:02 | Tide could be turning here... | phowdo | |
03/8/2015 12:43 | There are many events going forward that they have highlighted but this one today: 03/08/2015 | Boston, USA Bioprocessing Summit The 2015 Bioprocessing Summit plans to unite 750+ attendees from 30+ countries for five days of inspiring presentations and solutions. The Bioprocessing Summit brings together international leaders to discuss today's bioprocess issues from cell line selection to manufacturing. The Summit provides practical details in a relaxed, congenial atmosphere that promotes information exchange and networking. This leading bioprocess meeting is hosted in Boston each summer. Hundreds of bioprocess professionals come together each year at the Summit to share practical solutions for today’s bioprocess challenges with researchers from around the world. They are one of the sponsors | mirandaj | |
24/7/2015 10:36 | Be patient!! It will make a beautiful bowl when that starts forming. | llwyd | |
24/7/2015 06:53 | Ha ha - thanks gargle - appreciated. | deltrotter | |
24/7/2015 05:47 | Hate to say you out of the picture delboy - so here is the piece! 15 for 2015 update: Horizon Discovery Horizon Discovery (HZD:AIM) 157.8p Loss to date: 10.9% Original entry price: Buy at 182.5p, 23 Dec 2014 The life sciences group has lost a third of its value since peaking at 235p in January as the market grows impatient about a lack of newsflow. A trading update (20 Jul) did nothing to change the situation despite confirmation of a 112% year-on-year increase in half-year revenue to £8.6 million. The £151.8 million cap stands to collect undisclosed royalties and £158 million in milestone payments if all its projects reach the market – but timing remains uncertain. Horizon has a huge pipeline and is chasing high rewards but still needs regular upbeat newsflow to stop its shares drifting. Be patient. (MD) | gargleblaster | |
23/7/2015 20:40 | Any Shares Magazine subscribers care to say what the mag said about HZD today? | deltrotter | |
21/7/2015 13:17 | Horizon are in a very very new bioscience area including personalised medicines for cancer. There is great promise there, only there is no promise ... just a lot of likelihood, rather. Even when a product does get brought out, there is also a lot of testing to be done, with possible disappointments, before marketing such that profits arise, and they will be down the line from that point too. Soooo ... a speculative buy, IMHO; but I have, and recent price weakness will tempt me to buy more. This is one of those cases where averaging down is worth doing, I believe. | andrewbaker | |
20/7/2015 21:05 | Really impressive young CEO that guy IMO. | deltrotter | |
20/7/2015 11:50 | Still looks like a bit of an overhang of stock despite that news. Will clear eventually I suppose. Deferred gratification and marshmallow tests spring to mind. | phowdo | |
20/7/2015 11:43 | Horizon Discovery Group PLC (LON:HZD)‘s stock had its “buy” rating reiterated by research analysts at Panmure Gordon in a report released on Monday, AnalystRatingsNetwor Horizon Discovery Group PLC (LON:HZD) opened at 160.2501 on Monday. Horizon Discovery Group PLC has a 1-year low of GBX 143.00 and a 1-year high of GBX 237.00. The stock has a 50-day moving average of GBX 173.45 and a 200-day moving average of GBX 200.52. The company’s market cap is £125.52 million. A number of other analysts have also recently weighed in on HZD. Analysts at N+1 Singer reiterated a “buy” rating on shares of Horizon Discovery Group PLC in a research note on Monday. Separately, analysts at Beaufort Securities reiterated a “speculative buy” rating on shares of Horizon Discovery Group PLC in a research note on Friday, April 24th. Horizon Discovery Group plc is a life science company. The Company supplies research tools to organizations engaged in genomics research and the development of personalized medicines. The Company is a supplier of genetically-defined cell lines, reporter gene assay kits, genomic reference standards and contract research services to organizations engaged in bio-pharmaceutical process optimization, drug discovery and development, and clinical diagnostic development. The Company’s GENESIST gene editing and X MAN cell line platforms enable the understanding of the genetic basis of disease, the manipulation of genomes and the creation of genetically-defined human cell lines or patients in a test tube. In June 2014, the Company completed the acquisition of CombinatoRx service business (LON:HZD) business) and related assets from Zalicus Inc. | deltrotter | |
20/7/2015 09:34 | I hope you are right Cumbrian, just a small holding for me as risk/ reward ratio quite high but one I am happy to lock away for a couple of years. If I lose the lot it won't hurt but if it does well it will be like winning on the P Bonds | ayl30 | |
20/7/2015 09:19 | Been buying these since tipped in SCSW and Shares(only noticed recently) top lists for 2015. Currently 20% down but have been building a stake all the way down and currently have 39,000 @ 1.90ish average, so a top 5 position in my portfolio. Surprised at lack of activity this morning and as usual you can buy within spread with mid price of 161p. Still have a good feeling that during next few years this will turn into a great long term investment, having a cumulative effect of organic growth, bolt on acquisitions and R-D/success royalties. Guess we may have to wait until next year to see this really start to motor, but they are doing everything right at the moment and I retain the faith! | cumbrian2 | |
20/7/2015 08:57 | Looks fantastic RNS today. Hopefully this should mark a turning point in the share price. Or maybe stop the seller from selling. Great to be involved in such an exciting and progressive company. Not a massive holding for me, but hopefully this could eventually be a v profitable one. | oggyrocks | |
20/7/2015 08:04 | Well pleased with that statement. | cestnous | |
20/7/2015 07:45 | Cracking company, excellent management team, with great growth prospects over the next 5 years. Sellers been selling out of boredom and stop losses being hit I suspect. All IMHO. | deltrotter | |
20/7/2015 07:40 | Results this am seem impressive, any views? | ayl30 | |
17/7/2015 12:07 | Lots of sells these days | mj19 | |
10/7/2015 12:57 | Increased my holding today. | cestnous |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions